|
⚲
|
| Keyboard |
| Cohlhepp Ryan
✚
|
|
|---|---|
| CIK # | 0002034665 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002034665] | |
| 4 | [0002034665] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bicara Therapeutics Inc | |
| Cohlhepp Ryan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-16 | Sell | 4,500 | $19.66 | 88,470 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-16 | Sell | 8,000 | $19.66 | 157,280 |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 8,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-16 | Option exercise | 8,000 | $3.79 | 30,320 |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2026-03-03 | Option exercise | 12,892 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-03 | Sell | 12,892 | $18.16 | 234,119 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-03 | Option exercise | 12,892 | $3.79 | 48,861 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-03-03 | Sell | 4,500 | $18.16 | 81,720 |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2026-02-25 | Option exercise | 3,108 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-02-25 | Option exercise | 3,108 | $3.79 | 11,779 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-02-25 | Sell | 3,108 | $18.04 | 56,068 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-02-25 | Sell | 523 | $18.04 | 9,435 |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 300,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-01-22 | Sell | 3,828 | $18.10 | 69,287 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2026-01-15 | Sell | 149 | $18.02 | 2,685 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2025-12-26 | Option exercise | 25,000 | $4.44 | 111,000 |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2025-12-26 | Option exercise | 25,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Option exercise | 8,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2025-12-15 | Sell | 4,500 | $18.68 | 84,060 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2025-12-15 | Sell | 8,000 | $18.68 | 149,440 |
| showing 20 of 37 most recent transactions | |||||